Poor CYP expression was expected in leukocytes of patients with end-stage renal disease; however, the expression of CYP1A2, CYP2C9, CYP2C19 and CYP3A4 was efficiently quantified using the refined method. This evidence concerns the gene CYP1A2 and stage 5 chronic kidney disease.